Delivery Order SPE2DR25D2012-SPE2DR26F1BMT
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,059.07 delivery order for Varivax vaccine with diluents on December 3, 2025, with an ultimate completion date of December 24, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The vaccine delivery will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Varivax vaccine with diluents, valued at $4,997.30 with a firm fixed price structure. The contract is non-competitive and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. Performance will be...
- The Defense Logistics Agency awarded a $134,778.88 delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of August 12, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,039.38 on November 28, 2025, for the supply of Varivax vaccine with diluents. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The delivery order is scheduled for completion by December 19, 2025, and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Varivax vaccine with diluents, valued at $3,127.68. This firm fixed price delivery order, with an ultimate completion date of November 10, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VARIVAX vaccine with diluents on August 12, 2025, with a ceiling value of $1,032.11 and an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The work...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,846.51 for Varivax vaccine with diluents on September 8, 2025, with an ultimate completion date of September 29, 2025. This is a firm fixed price, non-competitive delivery order with performance in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply relationship with DLA, leveraging the company's extensive capabilities as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on November 7, 2025, with a ceiling value of $1,998.92 and an ultimate completion date of December 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Varivax vaccine with diluents, valued at $1,019.65 with a completion date of December 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $2,085.12 delivery order to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price contract, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's...
- SPE2DR25D2012Indefinite Delivery Contract
- SPE2DR25D2012-SPE2DR26F1BMTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,024.38 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on December 8, 2025, with an ultimate completion date of December 30, 2025. This competitive delivery order, utilizing firm fixed pricing, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor and critical federal medical procurement vendor. As a prime contractor for the DLA's comprehensive global pharmaceutical support vehicle, AmerisourceBergen supplies a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and related medical commodities. This particular delivery order for Varivax vaccine falls within the company's extensive portfolio of vaccine and immunization products supplied to federal healthcare systems serving the Defense Health Agency, U.S. Coast Guard, and other government entities. The contract contains no set-aside designation and was awarded through open competition, consistent with AmerisourceBergen's demonstrated capability to meet federal procurement requirements across multiple therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 12/7/25 |